Recent Updates
Recently added Catalysts
HCM Neutral Sentiment Score: 50/100

HUTCHMED Announces Board of Directors and Board Committee Membership Hong Kong, Shanghai & Florham Park, NJ - Friday

Key Takeaway: HUTCHMED (China) Limited has announced the deferred appointments of Professor Solange Peters as an Independent Non-executive Director, a member of its Technical Committee, and the Audit Committee, initially set to take effect after the AGM on May 12, 2023. Additionally, Professor Mok Shu Kam, Tony is announced to join the Audit Committee, contingent on his re-election by shareholders. The delay in appointments is a key detail in this announcement, reflecting potential shifts in governance structure.

Market Sentiment Analysis

Full Press Release Details

HUTCHMED Announces Board of Directors and Board Committee Membership
Hong Kong, Shanghai & Florham Park, NJ - Friday, May 12, 2023: HUTCHMED (China) Limited ("HUTCHMED" or the "Company") (Nasdaq/AIM: HCM, HKEX: 13) refers to its announcement on May 10, 2023 of the appointment of Professor Solange Peters as an Independent Non-executive Director, member of the Technical Committee and member of the Audit Committee of the Company with effect from the conclusion of the annual general meeting of the Company to be held on May 12, 2023 ("AGM"). The Company today announces that the effective date of such appointments will be deferred until a later date to be announced by the Company.
The Company also announces that Professor Mok Shu Kam, Tony will be appointed as member of the Audit Committee of the Company at the conclusion of the AGM, subject to Professor Mok being re-elected as a Director by the shareholders at the AGM.
Forward-Looking Statements
This announcement contains forward-looking statements within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect HUTCHMED's current expectations regarding future events. Forward-looking statements involve risks and uncertainties. Such risks and uncertainties include, among other things, the risk that current or future appointees to HUTCHMED's board of directors are not e ective in their respective positions, the di iculty in locating and recruiting suitable candidates for its board of directors and the management di iculties which may arise from changes in HUTCHMED's board of directors. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. For further discussion of these and other risks, see HUTCHMED's filings with the U.S. Securities and Exchange Commission, on A M and with The Stock Exchange of Hong Kong Limited. HUTCHMED undertakes no obligation to update or revise the information contained in this announcement, whether as a result of new information, future events or circumstances or otherwise.
Investor Enquiries
Mark Lee, Senior Vice President +852 2121 8200
Annie Cheng, Vice President +1 (973) 306-4490
Media Enquiries
Americas - Brad Miles, Solebury Strategic Communications +1 (917) 570 7340 (Mobile) / bmiles@soleburystrat.com
Europe - Ben Atwell / Alex Shaw, FTI Consulting +44 20 3727 1030 / +44 7771 913 902 (Mobile) / +44 7779 545 055 (Mobile) / HUTCHMED@fticonsulting.com
Asia - Zhou Yi, Brunswick +852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com
Nominated Advisor
Atholl Tweedie / Freddy Crossley / Daphne Zhang, Panmure Gordon +44 (20) 7886 2500

Frequently Asked Questions

Who was appointed as a non-executive director at HUTCHMED?

Professor Solange Peters was appointed as an Independent Non-executive Director.

When will Professor Solange Peters' appointment take effect?

The effective date of Professor Peters' appointment will be announced later.

Who will join the Audit Committee at HUTCHMED?

Professor Mok Shu Kam, Tony will join the Audit Committee if re-elected.

What laws relate to the forward-looking statements in the announcement?

The U.S. Private Securities Litigation Reform Act of 1995 pertains to these statements.

Who should investors contact for inquiries about HUTCHMED?

Mark Lee and Annie Cheng are the contacts for investor inquiries.

Last updated: May 12, 2023